Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements in the regenerative medicine sector.
NeoStem Announces Geographic Expansion of Intellectual Property in Canada
NeoStem Announces Geographic Expansion of Intellectual Property Coverage of AMR-001 to Canada 06/17 08:52 AM NEW YORK, June 17, 2013 (GLOBE NEWSWIRE) — NeoStem,...
Bioheart Announces Phase I ANGEL Trial Completed
June 12, 2013 07:08 ET SUNRISE, FL–(Marketwired – Jun 12, 2013) – Bioheart, Inc. (OTCQB: BHRT) announced today that they have successfully enrolled and...
BioRestorative Therapies CEO Mark Weinreb Interviewed on “Next Big Thing”
BioRestorative Therapies CEO Mark Weinreb Interviewed on “Next Big Thing” with Financial Personality and Founder Tobin Smith Discusses Company’s Unique Business Model and Pipeline of Products 06/17 08:00 AM JUPITER, Fla., June 17, 2013 /PRNewswire/ — BioRestorative Therapies, Inc. (BRTX:$1.00,00$0.00,000.00%) (“BRT” or the “Company”) – Financial personality and Founder of NBT Equities Research, Tobin Smith, recently interviewed BioRestorative Therapies, Inc. (BRTX:$1.00,00$0.00,000.00%) (the “Company”) CEO, Mark Weinreb, on the firm’s hybrid business model and what the firm is currently doing that will help change the biotechnology landscape. BioRestorative is a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications. NBT Equities Research interviews CEOs and industry leaders in the emerging growth sector and emerging growth sector advocacy groups to discuss trends and developments along with company updates. Topics discussed by Mr. Weinreb include an update on the Company’s ThermoStem™ Program designed to develop treatments...
NeoStem Announces Geographic Expansion of Intellectual Property in Canada
NeoStem Announces Geographic Expansion of Intellectual Property Coverage of AMR-001 to Canada 06/17 08:52 AM NEW YORK, June 17, 2013 (GLOBE NEWSWIRE) — NeoStem, Inc. (NBS:$0.54,00$0.00,000.00%) (“NeoStem” or the “Company”), a leader in the emerging cellular...
Stem cell pioneer Dr. James Thomson receives 2013 McEwen Award For Innovation
(TORONTO, Canada – June 12, 2013) – One of the world’s most renowned scientists, Dr. James A. Thomson, has been selected as the 2013 recipient of the McEwen Award for Innovation. Dr. Thomson was recognized for...